HR 3891 112th Congress House

SPRINT Act

Official title: To amend the Public Health Service Act to speed American innovation in research and drug development for the leading causes of death that are the most costly c… Show full official titleShow less

Official title: To amend the Public Health Service Act to speed American innovation in research and drug development for the leading causes of death that are the most costly chronic conditions for our Nation, to save American families and the Federal and State governments money, and to help family caregivers.

Introduced: February 2, 2012 Introduced by: Markey, Edward J. Democratic · Massachusetts See on congress.gov

Health Advanced technology and technological innovationsDrug safety, medical device, and laboratory regulationDrug therapyGovernment information and archives

More subjectsShow fewer subjects

Health care costs and insuranceHealth programs administration and fundingHealth technology, devices, suppliesLong-term, rehabilitative, and terminal careMedicaidMedical researchMedicarePublic-private cooperationResearch administration and fundingResearch and development

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Feb 2, 2012

Referred to the House Committee on Energy and Commerce.

Feb 2, 2012

Introduced in House

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Latest action February 2, 2012

Referred to the House Committee on Energy and Commerce.

Plain-English summary Congressional Research Service

Spending Reductions through Innovations in Therapies Agenda Act of 2012 or the SPRINT Act - Amends the Public Health Service Act to direct the Secretary of Health and Human Services (HHS) to establish the Spending Reductions through Innovations in Therapies Program (SPRINT Program) to support development of therapies to reduce spending by federal health care programs for high-cost chronic conditions. Requires the Program to: (1) accelerate advanced research and development of such therapies, and (2) encourage innovation in technologies that may assist such research to reduce the time and cost of therapy development.

Requires the Secretary to select the high-cost chronic conditions that shall be the focus of the Program from conditions among the top 10 leading causes of death designated by the Centers for Disease Control and Prevention (CDC) that have: (1) the highest current and projected cost to federal health care programs and high long-term care costs; (2) a likelihood of impairing the ability of an individual to carry out activities of daily living, which can result in the individual becoming dependent on caregivers; (3) a death rate that has increased and is projected to increase significantly in future years; and (4) a lack of existing therapies to prevent, control, or cure the condition or delay cognitive decline.

Sets forth the duties of the Secretary, including to: (1) partner with certain nonprofit strategic investment entities, (2) reduce the time and cost barriers between laboratory discoveries and clinical trials for therapies used to treat high-cost chronic conditions, and (3) facilitate innovative and expedited review by the Food and Drug Administration (FDA) of the therapies developed.

Establishes a SPRINT Award Program, under which the Secretary may award contracts or grants to public, nonprofit, early stage companies or growth companies to support advanced research and the development of therapies. Sets forth matching fund requirements. Requires the Secretary to evaluate projects funded.

Related & companion bills 1

Bill text 1 version